Research Progress on Hemoglobin Expression in Non‐Erythroid Cells and Tumor Cells
Journal of Cellular Physiology · 2026-09 · 241 (9)
DOI: 10.1002/jcp.70228 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular Physiology, online erschienen am 13.09.2026. Verfasst von Wu Xiaohui und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Xi'an Medical University, Xi'an, China. Hauptthemen laut MEDLINE: Hemoglobins, Neoplasms. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Scientific Research Capacity Enhancement Plan of Xi'an Medical University, Innovation and Entrepreneurship Program for College Students of Xi'an Medical University, Humanities and Social Science Project of the Ministry of Education of China.
Abstract (Originalsprache)
Hemoglobin (Hb) is traditionally recognized as an erythroid‐specific protein with the core function of mediating transmembrane transport of oxygen and carbon dioxide. In recent years, emerging studies have confirmed that hemoglobin is also expressed in the cytoplasm of various normal somatic cells and tumor cells. In normal somatic cells such as alveolar epithelial cells, vascular endothelial cells and chondrocytes, hemoglobin exerts multiple biological functions including oxygen storage, protection of smooth muscle soluble guanylate cyclase from excessive desensitization to nitric oxide, as well as hypoxia resistance, blood pressure regulation and antioxidant effects. In most tumor cells, hemoglobin expression is abnormally upregulated, while a small number of cases show a downregulated trend. Its expression level is closely associated with malignant biological behaviors of tumor cells such as survival, radioresistance and distant metastasis, making it a potential biomarker for tumor diagnosis and prognostic evaluation. This paper systematically reviews the discovery process and functional research progress of hemoglobin in normal non‐erythroid somatic cells and tumor cells, explores the feasibility of hemoglobin as a therapeutic target for related diseases, and provides new ideas and directions for the diagnosis and treatment of these diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, Xi'an Medical University, Xi'an, China.
- School of Medical Technology, Xi'an Medical University, Xi'an, China.
- Sports Department, Xi'an Medical University, Xi'an, China.
ORCID-Profile: Wu Xiaohui, Bai Yuke, Zhu Jiahao, Yan Bing, Song Jingyi, Chen Liang
Förderung
- Scientific Research Capacity Enhancement Plan of Xi'an Medical University
- Innovation and Entrepreneurship Program for College Students of Xi'an Medical University
- Humanities and Social Science Project of the Ministry of Education of China
Zitieren
APA
Xiaohui, W., Yuke, B., Jiahao, Z., Bing, Y., Jingyi, S., & Liang, C. (2026). Research Progress on Hemoglobin Expression in Non‐Erythroid Cells and Tumor Cells. Journal of Cellular Physiology, 241(9). https://doi.org/10.1002/jcp.70228
Vancouver
Xiaohui W, Yuke B, Jiahao Z, Bing Y, Jingyi S, Liang C. Research Progress on Hemoglobin Expression in Non‐Erythroid Cells and Tumor Cells. Journal of Cellular Physiology. 2026;241(9). doi:10.1002/jcp.70228
BibTeX
@article{Xiaohui2026,
author = {Xiaohui, Wu and Yuke, Bai and Jiahao, Zhu and Bing, Yan and Jingyi, Song and Liang, Chen},
title = {Research Progress on Hemoglobin Expression in Non‐Erythroid Cells and Tumor Cells},
journal = {Journal of Cellular Physiology},
year = {2026},
volume = {241},
number = {9},
doi = {10.1002/jcp.70228}
}
EUVIMED